Citations

Mayo Clinic

Clear

669 citation(s) found for "Xu, Can".

Faculty Opinions recommendation of The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas.
Jelinek, Diane F., Wu, Xiaosheng

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 18, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.1120794.577045 Get It

Faculty Opinions recommendation of Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.
Jelinek, Diane F., Tschumper, Renee C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 17, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.1163502.625240 Get It

Faculty Opinions recommendation of Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size?
Augoustides, John , Ramakrishna, Harish

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 17, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.1164431.626179 Get It

Faculty Opinions recommendation of Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.
Maher, Jim

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | August 20, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.12179956.14635118 Get It

Faculty Opinions recommendation of Can three-dimensional echocardiography accurately predict complexity of mitral valve repair?
Augoustides, John , Ramakrishna, Harish

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 31, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.14267035.15779158 Get It

Simulation-Based Training for Bedside Assistants Can Benefit Experienced Robotic Prostatectomy Teams
Thiel, David D. , Lannen, Amy, Richie, Eugene, Dove, Jesse, Gajarawala, Nikunj M., Igel, Todd C.

Journal of Endourology | July 31, 2012 | Volume: 27 | Issue: 2 | Pages: 230-237

10.1089/end.2012.0382 | PMID 22849341 Get It

Abstract 2582: P2X7 receptor is functional in myeloma cell lines and myeloma patient cells and can be modulated by P2X7 receptor antagonists: Implications for myeloma therapy
Donovan, Kathleen A., Moon‐Tasson, Laurie L., Hromockyj, Alexander E., Meyer, Debra M., Lust, John A.

Cancer Research | June 27, 2012 | Volume: 71 | Issue: 8_Supplement | Pages: 2582-2582

10.1158/1538-7445.am2011-2582 Get It

Abstract Inflammation is a driving factor in the pathogenesis of many cancers including multiple myeloma. Myeloma is a plasma cell tumor whose early stages are characterized by cytokine dependent growth, predominantly driven by IL-6. We have demonstrated that IL-1β is a key inducer of IL-6 expressed by bone marrow stromal cells in a paracrine fashion. The P2X7 receptor (P2X7R) is an ATP-gated ion channel expressed by cells of the hematopoetic lineage that has been shown to play a critical role in IL-1β processing and secretion. We investigated the role this receptor may play in the IL-1/IL-6 cytokine pathway in multiple myeloma. A panel of multiple myeloma cell lines was evaluated by RT-PCR for the expression of P2X7R mRNA. Levels of expression in ANBL-6, MM1S, U266, RPMI-8226 and KAS-6/1 were comparable to U937, a previously characterized P2X7R positive cell line. A newly derived plasmacytoma cell line, PCYT3, showed very low levels of message expression. The ability of ATP to trigger the processing and release of IL-1β by activation of the P2X7 channel was studied using KAS-Pro, a myeloma cell line stably transfected with a pro- IL-1β gene. IL-1β, measured by ELISA, was released in a dose dependent fashion in response to increasing amounts of ATP ranging from 1mM to 5mM. Three P2X7R specific antagonists were tested for their effect on ATP stimulated IL- 1β release from KAS-Pro; all 3 compounds demonstrated inhibition in a dose dependent manner with varying degrees of potency correlating with P2X7R inhibition. In addition fresh patient samples (15 multiple myelomas/ 4 smoldering myelomas/8 MGUS) were evaluated for inhibition of IL-1β release by the P2X7R antagonists through direct measurement of IL-1β by ELISA as well as by an indirect measurement of IL-1β induced IL-6 production by normal bone marrow stromal cells. Greater than 90% inhibition of IL-1β release was demonstrated in all MM & SMM patients positive for IL-1β expression. IL-1β was not detected in any of the MGUS patients and therefore no affect of the inhibitors was observed. These results confirm the activity of functional P2X7 receptors on myeloma cell lines and in fresh patient samples and suggest a role for the use of P2X7 receptor antagonists in the therapy of myeloma. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2582. doi:10.1158/1538-7445.AM2011-2582
Abstract A82: Can telomere length be modified in healthy people?
Washechek-Aletto, Jill, Thibodeau, Stephen N. , Petersen, Gloria M. , Cunningham, Julie M. , Boardman, Lisa A., Opyrchal, Seung M. L., Devine, Megan M., Viker, Kimberly, Johnson, Ruth, Engelman, Corinne D. , Boardman, Lisa A., Skinner, Halcyon G. , Seo, Songwon , Gangnon, Ronald E. , Litzelman, Kristin

Cancer Prevention Research | June 27, 2012 | Volume: 4 | Issue: 10_Supplement | Pages: A82-A82

10.1158/1940-6207.prev-11-a82 Get It

Abstract Short constitutional telomere length has been associated with aging and cancer, but how telomere length is affected by other epidemiologic or environmental variables in health has not been thoroughly studied. Understanding these associations with telomere length in health is important for studies to evaluate the relationship of telomere length and diseases such as cancer. We measured peripheral blood leukocyte DNA telomere length with quantitative PCR in 1977 non-related healthy controls collected through the Colon Cancer Family Registry (an NCI cooperative group) and through the Mayo Biobank and Biobank for Gastrointestinal Health Research, two IRB approved prospective biospecimen collections based at Mayo Clinic, Rochester, MN. The controls were a median age of 50.6 years old, and 49.6% of the controls were male. Ninety-six percent of the controls were white; 1.8% were Asian, and <1% were either black, Pacific Islander, or Native American. Less than 1% of controls were Hispanic. On univariate analysis, as age increased, telomere length decreased (Pearson correlation coefficient = −0.07, 95% CI: −0.11, −0.03). Telomeres were longer in people who consumed more fruits (p<0.01) and vegetables (p<0.01); took aspirin on a regular basis (p<0.01); or had a family history of cancers of any type (p=0.05). Women had longer telomeres than men (p=0.03). Telomeres were shorter in people who consumed alcohol (p<0.01), took folate on a regular basis (p=0.01), or who consumed red meat (p<0.01). Statistical significance was not found in the following variables: tobacco use, diagnosis of diabetes, intake of calcium, use of hormone replacement therapy in women, or body mass index. On multivariate analysis, age, vegetable consumption, family history of colorectal cancer or any type of cancer, and folate intake were identified as being significantly associated with telomere length. Telomere length may be associated with multiple environmental and demographic variables in healthy individuals, and adjusting for these may be important for studies that test for an association between telomere length and diseases such as cancer. Citation Information: Cancer Prev Res 2011;4(10 Suppl):A82.
β 1 Integrins Participate in the Hypertrophic Response of Rat Ventricular Myocytes
Ross, Robert S. , Pham, Can G., Shai, Shaw‐Yung, Fenczik, Csilla A., Glembotski, C C, Loftus, Joseph C. , Goldhaber, Joshua I. , Ginsberg, Mark H.

Circulation Research | June 12, 2012 | Volume: 82 | Issue: 11 | Pages: 1160-1172

10.1161/01.res.82.11.1160 | PMID 9633916 Get It

Abstract —Multiple signaling pathways have been implicated in the hypertrophic response of ventricular myocytes, yet the importance of cell-matrix interactions has not been extensively examined. Integrins are cell-surface molecules that link the extracellular matrix to the cellular cytoskeleton. They can function as cell signaling molecules and transducers of mechanical information in noncardiac cells. Given these properties and their abundance in cardiac cells, we evaluated the hypothesis that β 1 integrin function is involved in the α 1 -adrenergic mediated hypertrophic response of neonatal rat ventricular myocytes. The hypertrophic response of this model required interaction with extracellular matrix proteins. Specificity of these results was confirmed by demonstrating that ventricular myocytes plated onto an anti–β 1 integrin antibody supported the hypertrophic gene response. Adenovirus-mediated overexpression of β 1 integrin augmented the myocyte hypertrophic response when assessed by protein synthesis and atrial natriuretic factor production, a marker gene of hypertrophic induction. DNA synthesis was not altered by integrin overexpression. Transfection of cultured cardiac myocytes with either the ubiquitously expressed β 1A integrin or the cardiac/skeletal muscle–specific β 1 isoform (β 1D ) activated reporter expression from both the atrial natriuretic factor and myosin light chain-2 ventricular promoters, genetic markers of ventricular cell hypertrophy. Finally, suppression of integrin signaling by overexpression of free β 1 integrin cytoplasmic domains inhibited the adrenergically mediated atrial natriuretic factor response. These findings show that integrin ligation and signaling are involved in the cardiac hypertrophic response pathway.
Can Sarcoidosis and Metastatic Bone Lesions Be Reliably Differentiated on Routine MRI?
Moore, Sandra, Kransdorf, Mark J. , Schweitzer, Mark E. , Murphey, Mark D. , Babb, James S. , Babb, James S

American Journal of Roentgenology | May 22, 2012 | Volume: 198 | Issue: 6 | Pages: 1387-1393

10.2214/ajr.11.7498 | PMID 22623553 Get It